bioAffinity Technologies, Inc.
BIAF · Healthcare · $3M
After-hours $6.73-2.18%
Price
$12.65
$6.88
Jul 1, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$2M+26.1%
6/'26 vs prev quarter
Company Health
Market Cap$3M
Operating Margin-209.8%
Cash on Hand$2M86.2% of market cap
Among 39 Medical - Diagnostics & Research peers
LowMedianHigh
PSR0.5xmedian 5.4xPBR0.8xmedian 2.9xROE-402.9%median -4.1%bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer DiagnosticSep 17
bioAffinity Technologies Regains Compliance with Nasdaq Listing RequirementsSep 9
bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceSep 3
bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer SurvivorsSep 1
